Arca
Skip to content

Sl-Plus Lateralized Stem

Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented. 510(k) K021178, from Plus Orthopedics (San Diego, CA). Product code JDI, class 2.

As of Nov 17, 2026, K021178 is an FDA 510(k) held by Plus Orthopedics, substantially equivalent on May 14, 2002 after 29 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: May 14, 2002
  • Review time: 29 days
  • Recalls: 0
  • Cited as a predicate by: 4 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The SL-PLUS® Lateralized Stem is intended for treating patients who are candidates for total hip arthroplasty because the natural femoral head and neck has been subject to disease or trauma. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.

Cited as a Predicate

4 later 510(k) summaries name this device as a predicate

Other JDI Clearances

The newest 510(k)s for the same product code; their median review was 219 days; see every JDI device

Record

Type
Special
Received
Apr 15, 2002
Review panel
Orthopedic
Regulation
21 CFR 888.3350

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.